NFKB1 and neoplasm: TM can inhibit angiogenesis and reduce blood supply to tumor tissues by supressing transcription factors (NF-kB) and reduce tumor proliferative activity by inhibiting mitochondrial CCO function to reduce ATP production (88, 94).